MECOM and cancer: The genes simultaneously altered with TCL1b, TCL1 and Myr-Akt included Bcl-2, Cyclin D1, fibroblast growth factors, PDGFR, MCSFR (macrophage colony- stimulating factor receptor), AM1ETC (runt-related transcription factor 1), AMLEVI I (MDS1 and EVII complex locus runt-related transcription factor 1) or AML1 (runt-related transcription factor 1) in the cancer pathway of KEGG pathway mapping.